Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

3.6K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.6K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
The Proteasome01:13

The Proteasome

2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

10.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.5K
The Proteasome02:18

The Proteasome

5.0K
5.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

9.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin ± Pembrolizumab.

European urology oncology·2026
Same author

Tumor Heterogeneity Induces Pro- and Anti-metastatic Myeloid Cell Phenotypes in Breast Cancer Lung Metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer.

Clinical genitourinary cancer·2026
Same author

Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer.

Science (New York, N.Y.)·2026
Same author

Synergistic Treatment of Prostate Cancer and Multiple Myeloma using CD46-Targeted Radioimmunotherapy Antibody-Drug Conjugates.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.

JAMA ophthalmology·2025

Related Experiment Video

Updated: Mar 20, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K

Metalloproteinases: a Functional Pathway for Myeloid Cells.

Jonathan Chou1,2, Matilda F Chan3, Zena Werb1

  • 1Department of Anatomy, University of California, San Francisco, CA 94143.

Microbiology Spectrum
|May 27, 2016
PubMed
Summary

Metalloproteinases are key enzymes in myeloid cells, regulating immunity and tissue repair. This review explores their crucial roles in both healthy and diseased states.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

900
Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

5.2K

Related Experiment Videos

Last Updated: Mar 20, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

900
Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

5.2K

Area of Science:

  • Immunology and Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Myeloid cells are critical immune regulators involved in inflammation and tissue remodeling.
  • Metalloproteinases, including matrix metalloproteinases and adamalysins, are essential enzymes produced by myeloid cells.
  • These enzymes play multifaceted roles in biological processes, but their dysregulation is linked to various diseases.

Purpose of the Study:

  • To provide a comprehensive overview of the diverse functions of metalloproteinases in myeloid cells.
  • To highlight the proteolytic and non-proteolytic roles of these enzymes.
  • To emphasize the involvement of metalloproteinases in both physiological and pathological conditions.

Main Methods:

  • Literature review of studies on metalloproteinases and myeloid cells.
  • Analysis of the known substrates and functions of matrix metalloproteinases and adamalysins.
  • Synthesis of information regarding the impact of metalloproteinase dysregulation in disease.

Main Results:

  • Metalloproteinases mediate crucial functions such as proteolytic cascades, cell migration, and signaling.
  • They are involved in extracellular matrix turnover, inflammation, fibrosis, and cancer.
  • Non-proteolytic functions include regulation of cytoskeletal dynamics and enhancement of antiviral immunity.

Conclusions:

  • Metalloproteinases are indispensable for a wide range of myeloid cell functions.
  • Understanding these enzymes is vital for developing therapeutic strategies against diseases involving myeloid cells.
  • Further research into the non-proteolytic roles could reveal novel therapeutic targets.